BioPharma Clinical Trials
US FDA Grants Orphan Drug Designation to SN Bioscience's 'SNB-101' for Small Cell Lung Cancer
SNB-101 showed excellent efficacy in animal small cell lung cancer models, and based on this, it has been designated as an orphan drug by the US FDA after ...
July 21, 2023 | News
Lynk Pharmaceuticals Doses First Atopic Dermatitis Patient with LNK01004 in Phase Ib Study
The trial was designed to evaluate the safety, tolerability, pharmacokinetic characteristics and preliminary efficacy of LNK01004 ointment in Chinese patie...
July 21, 2023 | News
BioCity Initiates Phase 1 Trial with CDH3-Targeting ADC BC3195, First Patient Dosed
The study will assess the safety, tolerability, pharmacokinetics, and preliminary efficacy of BC3195 in patients with locally advanced or metastatic solid ...
July 20, 2023 | News
Merck and Telix Continue Collaboration for Targeted Radiation Therapy Studies.
Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the first patient has been dosed in a Phase I study of the Com...
July 19, 2023 | News
Mabwell Announces the NMPA Approval of Novel Trop-2 ADC (9MW2921) for IND
9MW2921 is a next generation antibody-drug conjugate (ADC) developed by Mabwell based on IDDC™ (Interchain-Disulfide Drug Conjugate) platef...
July 19, 2023 | News
Antengene Administers First Patient in US Clinical Study of ATG-017 for Advanced Solid Tumors with Nivolumab Combination
- ATG-017 is an oral, potent and selective small molecule ERK1/2 inhibitor. Antengene has exclusive global rights to develop...
July 18, 2023 | News
Antengene's XPOVIO® Approved in Hong Kong for Relapsed Multiple Myeloma
XPOVIO® has received regulatory approvals in 41 countries and regions including the United States, Israel, the United Kingdo...
July 17, 2023 | News
Menarini Silicon Biosystems Launches New CELLSEARCH® CTC Test for Small Cell Lung Cancer with DLL3 Biomarker
Menarini Silicon Biosystems (MSB), a pioneer in liquid biopsy and single cell technologies, announced today the availability of its new CELLSEARCH CTC...
July 14, 2023 | News
Velico Medical begins clinical trial on Spray Dried Plasma
This first in-human clinical trial using Velico's spray drying system is taking place at Hoxworth Blood Center, Cincinnati, Ohio; Versiti Blood Center...
July 13, 2023 | News
Discovery Life Sciences Boosts Clinical Trials with Full-Spectrum Clinical Flow Cytometry
Discovery Life Sciences (Discovery), the Biospecimen and Biomarker Specialists, announces the launch of state-of-the-art flow cytometry clinical trial serv...
July 12, 2023 | News
Broncus Completes First Registered Clinical Trials of Targeted Lung Denervation System
The multi-center clinical randomized controlled trial on the ''treatment of Chronic Obstructive Pulmonary Disease (''COPD'') by targeted lung denervation a...
July 11, 2023 | News
RemeGen and Innovent Collaborate on Clinical Trials for Advanced Solid Tumors
RemeGen Co., Ltd. ("RemeGen" or "the Company") (HKG: 9995, SHA: 688331), a fully-integrated commercial-stage biotechnology company, announce...
July 10, 2023 | News
280 Bio receives IND approval from the FDA for YL-17231
80Bio, Inc. a clinical stage biotechnology company focused on the development of precision oncology medicines, today announced that the U.S. Food and Drug ...
July 10, 2023 | News
Transcenta Receives Approvals for Global Phase III Trial of Osemitamab (TST001)
To initiate TranStar 301 global Phase III pivotal trial of Osemitamab (TST001) in combination with Nivolumab and chemotherapy for the first-line treatment ...
July 10, 2023 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
